• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Ventas Inc.

    4/16/25 5:16:14 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate
    Get the next $VTR alert in real time by email
    DEFA14A 1 vtr013361-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934

    þ Filed by the Registrant o Filed by a party other than the Registrant        

    CHECK THE APPROPRIATE BOX:
    o   Preliminary Proxy Statement
    o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    o Definitive Proxy Statement
    þ   Definitive Additional Materials
    o Soliciting Material under §240.14a-12

    Ventas, Inc.

    (Name of Registrant as Specified In Its Charter)
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
    þ   No fee required
    o Fee paid previously with preliminary materials
    o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


    Supplement to the Proxy Statement for the 2025 Annual Meeting of Stockholders to be held May 13, 2025

    This supplement, dated April 16, 2025 (this "Supplement"), supplements the definitive proxy statement of Ventas, Inc., a Delaware corporation (the "Company," "we," "us," "our" and similar terms), dated April 1, 2025 (the "Proxy Statement"), and is furnished to the Company's stockholders in connection with the solicitation of proxies on behalf of the Board of Directors of the Company (the "Board") for the Company's 2025 Annual Meeting of Stockholders to be held on May 13, 2025, or any postponement or adjournment thereof (the "2025 Annual Meeting"). This Supplement is being filed with the Securities and Exchange Commission and is first being made available to the Company's stockholders on or about April 16, 2025.

    Except to the extent described in this Supplement, none of the items or information contained in the Proxy Statement is affected by this Supplement. This Supplement does not provide all of the information that is important to your voting decisions at the 2025 Annual Meeting. The Proxy Statement contains other important additional information. We encourage you to carefully read this Supplement together with the Proxy Statement in their entirety.

    THE PROXY STATEMENT CONTAINS IMPORTANT INFORMATION AND THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.

    This Supplement updates, and to the extent inconsistent therewith, supersedes, the disclosure in the Proxy Statement to reflect that the New York Stock Exchange ("NYSE") notified the Company of its determination that Proposal 4 of the Proxy Statement, which seeks stockholder approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock, is a "routine" matter eligible for discretionary voting by brokers and other nominees under the NYSE rules.

    Pursuant to the NYSE rules, if you hold your shares through a broker or other nominee (i.e. in "street name") and do not instruct such broker or other nominee on how to vote your shares, your broker or other nominee is permitted to vote your shares in its discretion on "routine" matters as determined by the NYSE. This Supplement clarifies that the NYSE considers Proposal 4 to be a "routine" matter.

    As a result of the foregoing, the following updates are made to the Proxy Statement:

    The fourth row in the table under the heading "Vote Requirements, Board Recommendations and Voting Results" on page 99 of the Proxy Statement is hereby revised in its entirety to read as follows:

    ITEMS: Board Recommendation Vote Requirement for Approval Effect of Abstentions Effect of Broker Non-Votes
    4 To approve an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock
     
    FOR Majority of votes cast No effect Not applicable

    The paragraph under the heading "What are broker non-votes?" on page 100 of the Proxy Statement is hereby revised in its entirety to read as follows:

    A broker non-vote occurs when a beneficial owner does not provide voting instructions to the beneficial owner's broker or custodian with respect to a "non-routine" proposal, on which the broker or custodian does not have discretionary authority to vote. The ratification of the selection of KPMG LLP as our independent public accounting firm for fiscal year 2025 (Proposal 3) and the approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock (Proposal 4) are considered "routine" matters; brokers have discretionary authority to vote on those proposals.


    Get the next $VTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VTR

    DatePrice TargetRatingAnalyst
    10/1/2025$77.00Overweight
    Cantor Fitzgerald
    9/19/2025$73.00Neutral
    UBS
    6/23/2025$72.00Neutral → Overweight
    Analyst
    3/7/2025Hold → Buy
    Argus
    1/17/2025$66.00 → $65.00Neutral → Outperform
    Robert W. Baird
    10/1/2024$61.00 → $71.00Equal Weight → Overweight
    Wells Fargo
    3/18/2024$50.00In-line → Outperform
    Evercore ISI
    2/26/2024$52.00 → $46.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $VTR
    SEC Filings

    View All

    Ventas Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Ventas, Inc. (0000740260) (Filer)

    12/4/25 4:52:30 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form FWP filed by Ventas Inc.

    FWP - Ventas, Inc. (0000740260) (Subject)

    12/2/25 4:17:40 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B5 filed by Ventas Inc.

    424B5 - Ventas, Inc. (0000740260) (Filer)

    12/2/25 8:50:29 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ventas Declares Quarterly Dividend of $0.48 Per Common Share

    Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents

    12/10/25 4:55:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas to Participate in Investor Meetings at Nareit's REITworld 2025 Annual Conference

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") announced today that management will participate in investor meetings at Nareit's REITworld 2025 Annual Conference (the "Nareit Conference") on December 8-9, 2025. Written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on Monday, December 8, 2025 at 8:30 a.m. Eastern Time. Such materials will be archived at ir.ventasreit.com/events-and-presentations for a limited period following the event. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and

    12/5/25 5:08:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. "Pete has been instrumental in elevating and driving excellence across our Outpatient Medical & Research and Lillibridge businesses, benefitting the users of our exceptional environments and our shareholders," said Ventas Chairman & CEO Debra A. Cafaro. "His leadership has helped strengthen our client and partner relationships, expand our competitive

    11/17/25 8:00:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Cafaro Debra A exercised 10,322 shares at a strike of $73.71 and sold $831,419 worth of shares (10,322 units at $80.55) (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    12/3/25 4:05:28 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    EVP OM&R-Ventas/Pres&CEO-LHS Bulgarelli Peter J. sold $400,205 worth of shares (5,000 units at $80.04), decreasing direct ownership by 4% to 106,488 units (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    11/20/25 4:30:52 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Chairman and CEO Cafaro Debra A exercised 41,294 shares at a strike of $73.71 and sold $3,262,536 worth of shares (41,294 units at $79.01) (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    11/19/25 4:34:39 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Ventas with a new price target

    Cantor Fitzgerald initiated coverage of Ventas with a rating of Overweight and set a new price target of $77.00

    10/1/25 9:40:36 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    UBS initiated coverage on Ventas with a new price target

    UBS initiated coverage of Ventas with a rating of Neutral and set a new price target of $73.00

    9/19/25 7:41:59 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas upgraded by Analyst with a new price target

    Analyst upgraded Ventas from Neutral to Overweight and set a new price target of $72.00

    6/23/25 8:02:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Leadership Updates

    Live Leadership Updates

    View All

    Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

    Believes NHI is Significantly Undervalued with Opportunities to Unlock its Valuable Assets, Including Upcoming Lease Renewal with Tenant National Healthcare Corporation Highlights Poor Corporate Governance and Serious Conflicts of Interest Among Board Members Expresses Serious Concerns that NHI Board Cannot Fairly Represent Both Landlord and Tenant in Lease Renegotiation Given Substantial Economic and Personal Ties to NHC Discloses Likely Substantial Upside to Lease Rental Rates if Lease is Negotiated at Arms-Length Believes Shareholders Need to Send a Clear Message at Upcoming Annual Meeting – Ahead of Critical Lease Renegotiations – that Maintaining the Status Quo is Not an Option

    4/18/24 9:15:00 AM ET
    $NHC
    $NHI
    $SUI
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Ventas Appoints Theodore Bigman and Joe V. Rodriguez, Jr. to Board of Directors

    Enters Into Cooperation Agreement with Land & Buildings Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has appointed Theodore Bigman and Joe V. Rodriguez, Jr. to the Board, effective immediately. In connection with the appointments, which align with Ventas's ongoing focus on Board refreshment and maintaining strong governance, the Company has entered into a mutual cooperation agreement (the "Cooperation Agreement") with shareholder Land & Buildings Investment Management LLC ("Land & Buildings"). Mr. Bigman brings significant investing and capital markets experience, and has served as a private investor and as founder and Chief Investment Officer of Bigman Holdings,

    3/4/24 8:03:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ardent Announces Senior Leadership Appointments and Promotions

    Ardent Health Services today announced the appointment of two new senior operations leaders and the promotion of three executives to expanded roles. Mike Matthews has been appointed president of Ardent Physician Services. He will oversee Ardent's medical group operations across eight markets in six states while working closely with providers to create greater alignment across the continuum of care. Matthews was previously senior vice president at ScionHealth where he led the company's physician enterprise, which included more than 500 providers across 13 states. Prior to that, he served as regional vice president of physician services for Lifepoint Health. David Schultz has been named p

    4/12/23 10:00:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Financials

    Live finance-specific insights

    View All

    $VTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Ventas Declares Quarterly Dividend of $0.48 Per Common Share

    Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents

    12/10/25 4:55:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Reports 2025 Third Quarter Results

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the third quarter ended September 30, 2025. CEO Remarks "Ventas delivered strong financial performance and growth in the third quarter as we continued to execute on our 1-2-3 strategy. Results in the quarter were powered by our senior housing operating portfolio (SHOP), which experienced broad-based demand and grew organically year-over-year by double digits," said Debra A. Cafaro, Ventas Chairman and CEO. "We have also completed $2.2 billion in senior housing acquisitions in attractive markets year to date. These investments are expected to enhance our earnings and future growth rate. As we grow, our finan

    10/29/25 4:10:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Announces Third Quarter 2025 Earnings Release Date and Conference Call

    Ventas, Inc. (NYSE:VTR) will issue its third quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, October 29, 2025. A conference call to discuss those earnings will be held on Thursday, October 30, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call

    10/6/25 4:41:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Ventas Inc.

    SC 13G - Ventas, Inc. (0000740260) (Subject)

    10/15/24 1:39:07 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Ventas Inc. (Amendment)

    SC 13G/A - Ventas, Inc. (0000740260) (Subject)

    2/13/24 5:16:09 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Ventas Inc.

    SC 13G - Ventas, Inc. (0000740260) (Subject)

    2/9/24 10:05:20 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate